Risk factors for colistin-associated nephrotoxicity

Journal of Infection

Volumn 62, Issue 2, 2011, Pages 187-190

  Rattanaumpawan, Pinyo ^a   Ungprasert, Puangpaka ^a   Thamlikitkul, Visanu ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; CREATININE; VANCOMYCIN;

ADULT; AGE; AGED; CASE CONTROL STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MONITORING; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; THAILAND; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; COLISTIN; CREATININE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK FACTORS; THAILAND;

EID: 79551593925     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.11.013     Document Type: Letter

References (14)

1. Yau W., Owen R.J., Poudyal A., Bell J.M., Turnidge J.D., Yu H.H., et al. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J Infect 2009 Feb, 58(2):138-144.
2. Li J., Rayner C.R., Nation R.L., Owen R.J., Spelman D., Tan K.E., et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006 Sep, 50(9):2946-2950.
3. Beno P., Krcmery V., Demitrovicova A. Bacteraemia in cancer patients caused by colistin-resistant gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clin Microbiol Infect 2006 May, 12(5):497-498.
4. Hawley J.S., Murray C.K., Jorgensen J.H. Colistin heteroresistance in acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 2008 Jan, 52(1):351-352.
5. Rodriguez C.H., Bombicino K., Granados G., Nastro M., Vay C., Famiglietti A. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin. Diagn Microbiol Infect Dis 2009 Oct, 65(2):188-191.
6. Li J., Nation R.L. Old polymyxins are back: is resistance close?. Clin Infect Dis 2006 Sep 1, 43(5):663-664.
7. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 Aug, 8(4):R204-R212.
8. Koch-Weser J., Sidel V.W., Federman E.B., Kanarek P., Finer D.C., Eaton A.E. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med 1970 Jun, 72(6):857-868.
9. Falagas M.E., Fragoulis K.N., Kasiakou S.K., Sermaidis G.J., Michalopoulos A. Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents 2005 Dec, 26(6):504-507.
10. Deryke C.A., Crawford A.J., Uddin N., Wallace M.R. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrob Agents Chemother 2010 Jul 26, 54(10):4503-4505.
11. Hartzell J.D., Neff R., Ake J., Howard R., Olson S., Paolino K., et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 2009 Jun 15, 48(12):1724-1728.
12. Koomanachai P., Tiengrim S., Kiratisin P., Thamlikitkul V. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis 2007 Sep, 11(5):402-406.
13. Michalopoulos A.S., Tsiodras S., Rellos K., Mentzelopoulos S., Falagas M.E. Colistin treatment in patients with ICU-acquired infections caused by multiresistant gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 2005 Feb, 11(2):115-121.
14. Falagas M.E., Rafailidis P.I., Ioannidou E., Alexiou V.G., Matthaiou D.K., Karageorgopoulos D.E., et al. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 2010 Feb, 35(2):194-199.